Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed director
CC transcript
Inv. presentation
Acq. announced
Appointed CFO
|
|
Innoviva, Inc. (INVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| Koziel Margaret (Chief Medical Officer) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 60,000 options to buy
@ $13.55, valued at
$813k
|
|
| 06/07/2023 |
4
| DENNER ALEXANDER J (10% Owner) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Bought 7,000 shares
@ $13.0424, valued at
$91.3k
Bought 8,000 shares
@ $13.048, valued at
$104.4k
|
|
| 05/30/2023 |
4
| DENNER ALEXANDER J (10% Owner) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Bought 50,000 shares
@ $13.0866, valued at
$654.3k
Bought 30,000 shares
@ $13.1243, valued at
$393.7k
Bought 120,000 shares
@ $13.0054, valued at
$1.6M
|
|
| 05/24/2023 |
4
| Srivastava Sapna (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 16,495 shares
@ $0
Granted 10,000 options to buy
@ $13.64, valued at
$136.4k
|
|
| 05/24/2023 |
4
| Birx Deborah (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 16,495 shares
@ $0
Granted 10,000 options to buy
@ $13.64, valued at
$136.4k
|
|
| 05/24/2023 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 16,495 shares
@ $0
Granted 10,000 options to buy
@ $13.64, valued at
$136.4k
|
|
| 05/24/2023 |
4
| Haimovitz Jules (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 16,495 shares
@ $0
Granted 10,000 options to buy
@ $13.64, valued at
$136.4k
|
|
| 05/24/2023 |
4
| DiPaolo Mark (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 16,495 shares
@ $0
Granted 10,000 options to buy
@ $13.64, valued at
$136.4k
|
|
| 05/24/2023 |
4
| Odysseas Kostas D (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 16,495 shares
@ $0
Granted 10,000 options to buy
@ $13.64, valued at
$136.4k
|
|
| 05/23/2023 |
4
| Zhen Marianne (Chief Accounting Officer) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 1,576 shares
@ $0
Paid exercise price by delivering 784 shares
@ $13.47, valued at
$10.6k
|
|
| 05/19/2023 |
4
| DENNER ALEXANDER J (10% Owner) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Bought 50,000 shares
@ $13.0738, valued at
$653.7k
Bought 10,000 shares
@ $13.0538, valued at
$130.5k
|
|
| 05/15/2023 |
4
| DENNER ALEXANDER J (10% Owner) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Bought 290,000 shares
@ $12.3359, valued at
$3.6M
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
4
| Raifeld Pavel (CEO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Bought 3,000 shares
@ $10.8677, valued at
$32.6k
|
|
| 02/22/2023 |
4
| Zhen Marianne (Chief Accounting Officer) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 1,852 shares
@ $12.42, valued at
$23k
|
|
| 01/12/2023 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought options to buy
@ $1.52, valued at
$0 |
|
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Bought 11,671,662 shares
@ $2.2, valued at
$25.7M
Bought 7,598,814 shares
@ $2.2, valued at
$16.7M
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Birx Deborah (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 12,647 shares
@ $0
Granted 10,000 options to buy
@ $17.79, valued at
$177.9k
|
|
| 04/27/2022 |
4
| Bickerstaff George (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 12,647 shares
@ $0
Granted 10,000 options to buy
@ $17.79, valued at
$177.9k
|
|
| 04/27/2022 |
4
| Haimovitz Jules (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 12,647 shares
@ $0
Granted 10,000 options to buy
@ $17.79, valued at
$177.9k
|
|
| 04/27/2022 |
4
| DiPaolo Mark (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 12,647 shares
@ $0
Granted 10,000 options to buy
@ $17.79, valued at
$177.9k
|
|
| 04/27/2022 |
4
| Schlesinger Sarah J. (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 12,647 shares
@ $0
Granted 10,000 options to buy
@ $17.79, valued at
$177.9k
|
|
| 04/27/2022 |
4
| Odysseas Kostas D (Director) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 12,647 shares
@ $0
Granted 10,000 options to buy
@ $17.79, valued at
$177.9k
|
|
| 04/01/2022 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 5,385,208 shares
@ $5, valued at
$26.9M
Bought options to buy
@ $5, valued at
$0 |
|
| 03/02/2022 |
4
| Zhen Marianne (Chief Accounting Officer) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 6,691 shares
@ $0
Granted 15,000 options to buy
@ $18.68, valued at
$280.2k
|
|
| 02/23/2022 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Acquired options to buy
@ $1.48, valued at
$0
Acquired options to buy
@ $1.48, valued at
$0 |
|
| 02/22/2022 |
4
| Zhen Marianne (Chief Accounting Officer) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 2,277 shares
@ $19.99, valued at
$45.5k
|
|
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Zhen Marianne (Chief Accounting Officer) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 758 shares
@ $17.05, valued at
$12.9k
|
|
| 11/01/2021 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Bought 1,212,122 shares
@ $3.3, valued at
$4M
|
|
|
|
|